Unassociated Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K


CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported): December 19, 2007


NovaMed, Inc.
(Exact Name of Registrant as Specified in Charter)


Delaware_____
  
0-26625
  
36-4116193__
(State or Other Jurisdiction
  
(Commission
  
(IRS Employer
of Incorporation)
  
File Number)
  
Identification No.)


980 North Michigan Avenue, Suite 1620, Chicago, Illinois
  
60611
(Address of Principal Executive Offices)
  
(Zip Code)

Registrant’s telephone number, including area code (312) 664-4100
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Section 8 - Other Events

Item 8.01. Other Events

As previously disclosed, on December 12, 2007 the Board of Directors of NovaMed, Inc. (the “Company”) approved a plan to close or sell three ambulatory surgery centers located in Laredo, Texas, Thibodaux, Louisiana and Columbus, Georgia. Effective December 19, 2007, the Company sold its 71.5% interest in the Columbus, Georgia ambulatory surgery center and no longer has any involvement in the operations of this facility.

 
 
 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
  NovaMed, Inc.
 
 		  
 		  
 
Dated: December 31, 2007 By:   /s/ Thomas S. Hall
 
Thomas S. Hall
  Chairman of the Board, President and Chief Executive Officer